Robin Swartz, Chief Operating Officer at Voyager Therapeutics, Inc. (VYGR), sold 1,527 shares at $8.25 ($13K) on 2022-04-04, disclosed to the SEC on 2022-04-06.
Scheduled sale ($13k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-11 | $18K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $17K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $31K | — | Filing → |